{
 "name": "益得",
 "slug": "tw-6461",
 "aliases": [
  "益得生物科技股份有限公司",
  "Intech",
  "6461"
 ],
 "ticker": "6461",
 "industry": "生技醫療業",
 "website": "http://www.intechbiopharm.com",
 "summary": "益得（6461）是上櫃的生技醫療類股公司，2010 年成立，2018 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "益得生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "Intech",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2018-03-28",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2010-10-28",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "林智暉",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "Manish Chawla",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 1103245270,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.intechbiopharm.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 7207,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 18.13,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -51.78,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "管線：Duasma（budesonide）",
   "value": "氣喘｜已上市｜台灣、香港、哥斯大黎加、蒙古、菲律賓及馬來西亞",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://www.intechbiopharm.com/CKEdit/upload/files/202609080313.pdf",
   "note": "地區與階段依2026簡報；Duasma氣喘控制及Synvent氣喘緊急用藥用途補充公司110年報（刊印2022-05-05）第90頁：https://www.intechbiopharm.com/CKEdit/upload/201608231500492460/files/202212201106.pdf；SYN010適應症補充：https://www.intechbiopharm.com/product_detail.php?cat=201805020819550180&id=201805020936080250；不從授權推定美國已獲藥證。"
  },
  {
   "claim": "管線：Synvent（salbutamol）",
   "value": "氣喘緊急用藥｜已上市｜台灣、香港、蒙古、印尼、柬埔寨及緬甸",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://www.intechbiopharm.com/CKEdit/upload/files/202609080313.pdf",
   "note": "地區與階段依2026簡報；Duasma氣喘控制及Synvent氣喘緊急用藥用途補充公司110年報（刊印2022-05-05）第90頁：https://www.intechbiopharm.com/CKEdit/upload/201608231500492460/files/202212201106.pdf；SYN010適應症補充：https://www.intechbiopharm.com/product_detail.php?cat=201805020819550180&id=201805020936080250；不從授權推定美國已獲藥證。"
  },
  {
   "claim": "管線：SYN010（Synbufo；budesonide/formoterol）",
   "value": "氣喘及慢性阻塞性肺病｜已上市｜台灣及哥斯大黎加",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://www.intechbiopharm.com/CKEdit/upload/files/202609080313.pdf",
   "note": "地區與階段依2026簡報；Duasma氣喘控制及Synvent氣喘緊急用藥用途補充公司110年報（刊印2022-05-05）第90頁：https://www.intechbiopharm.com/CKEdit/upload/201608231500492460/files/202212201106.pdf；SYN010適應症補充：https://www.intechbiopharm.com/product_detail.php?cat=201805020819550180&id=201805020936080250；不從授權推定美國已獲藥證。"
  },
  {
   "claim": "管線：SYN010（Synbufo；budesonide/formoterol）",
   "value": "氣喘及慢性阻塞性肺病｜查驗登記送件中｜香港",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://www.intechbiopharm.com/CKEdit/upload/files/202609080313.pdf",
   "note": "地區與階段依2026簡報；Duasma氣喘控制及Synvent氣喘緊急用藥用途補充公司110年報（刊印2022-05-05）第90頁：https://www.intechbiopharm.com/CKEdit/upload/201608231500492460/files/202212201106.pdf；SYN010適應症補充：https://www.intechbiopharm.com/product_detail.php?cat=201805020819550180&id=201805020936080250；不從授權推定美國已獲藥證。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6461.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}